Auto Summaries

Last updated: 2024 Apr 18

Total hit(s): 16319

S.No.
1	38515937	Neutralization of SARS-CoV-2 infection by antibodies targeting diverse epitopes.	N/A	Genes Dis	2024 Jul	- n/a -	1
2	37852915	Diagnosis and therapy of tacrolimus toxicity in a liver transplant recipient during COVID-19 treatment.	N/A	Hepatobiliary Pancreat Dis Int	2024 Jun		1
3	38516392	Environmental surveillance of SARS-CoV-2 for COVID-19 outbreak detection in hospital: a single-centre prospective study.	N/A	Infect Prev Pract	2024 Jun	- n/a -	1
4	38602427	Time to Treatment Initiation and HIV Viral Suppression in People Diagnosed With HIV-1 During COVID-19 Pandemic in Ex-Aquitaine, France (ANRS CO3 AQUIVIH-NA Cohort-QuAliCOV Study): Erratum.	N/A	J Acquir Immune Defic Syndr	2024 May 1	3.51	1
5	38578138	When acute SARS-CoV-2 infection was a blessing in disguise! Unexpected diagnosis and clinical course of hepatopulmonary syndrome in a teenager.	N/A	Pediatr Pulmonol	2024 Apr 5	2.64	1
6	38566412	Admission diagnostics for SARS-CoV-2 and other respiratory viruses.	N/A	Acta Paediatr	2024 Apr 2	2.24	1
7	38614908	When calculating COVID-19 incidence, mandatory PCR testing should be preferred over voluntary antigen testing.	N/A	J Formos Med Assoc	2024 Apr 12	2.16	1
8	38600153	Author Correction: Symptoms and quality of life before, during, and after a SARSCoV2 PCR positive or negative test: data from Lifelines.	N/A	Sci Rep	2024 Apr 10	4.12	1
9	38511965	Erratum for Karaba et al., "Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment".	N/A	mBio	2024 Apr 10	6.5	1
10	38565180	Letter to the Editor: Myocarditis Associated With SARS-CoV-2 Vaccination Diagnosed by Cardiac MRI Requires Confirmation by Endomyocardial Biopsy.	N/A	J Korean Med Sci	2024 Apr 1	1.74	1
11	38565636	Author Correction: SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies.	N/A	Nature	2024 Apr	24.36	1
12	38502097	Patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension during the COVID-19 pandemic (2020-2022): clinical outcomes, prognostic factors, and response to vaccination.	N/A	Pol Arch Intern Med	2024 Mar 27	3.007	1
13	38511885	Correspondence on "Factors in Vaccine Refusal by Patients Applying for COVID-19 PCR Test".	N/A	Medeni Med J	2024 Mar 21		2
14	38511910	About on "Factors in Vaccine Refusal by Patients Applying for COVID-19 PCR Test".	N/A	Medeni Med J	2024 Mar 21		1
15	38506338	COVID-19 disease in patients with chronic neutropenia: The experience from the European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias.	N/A	Br J Haematol	2024 Mar 20	5.02	1
16	38462985	Gestational diabetes mellitus screening and diagnosis criteria before and during the COVID-19 pandemic: a retrospective pre-post study.	N/A	Med J Aust	2024 Mar 11	2.05	1
17	38462983	Gestational diabetes mellitus screening and diagnosis criteria before and during the COVID-19 pandemic: a retrospective pre-post study.	N/A	Med J Aust	2024 Mar 11	2.05	1
18	38416026	Using telenursing after discharge to counsel patients diagnosed with COVID-19.	N/A	Nurs Manage	2024 Mar 1	0.8	1
19	38461025	Potential of Muscle Mass Evaluation for Prognostic Prediction of COVID-19.	N/A	Chest	2024 Mar	7.22	1
20	38485336	When four is more - improved COVID-19 antibody responses with 4 doses of vaccine in CAR T-cell therapy recipients.	N/A	Transplant Cell Ther	2024 Mar	- n/a -	1
21	38402601	Comment on "The risk assessment of uveitis after COVID-19 diagnosis".	N/A	J Med Virol	2024 Mar	2.07	1
22	38335905	Convalescent plasma: An unexpected new therapeutic option for critically ill COVID-19 patients coming from the past.	N/A	J Clin Anesth	2024 Feb 8	2.74	1
23	38326113	Diagnostic typing and prognostic markers of covid-19: Insights from a retrospective observational study.	N/A	Asian J Surg	2024 Feb 7	3.9	1
24	38326320	Author Correction: A multiplexed, paired-pooled droplet digital PCR assay for detection of SARS-CoV-2 in saliva.	N/A	Sci Rep	2024 Feb 7	4.12	1
25	38311527	Antibody responses to SARS-CoV-2 vaccines in neuromuscular disorders may depend on their etiology and current drug treatment.	N/A	Rev Neurol (Paris)	2024 Feb 3	4	1